Table 2.

Frequency of first-line chemotherapeutic regimens and incidence of AE-ILD during first-line chemotherapy

	Bev group (n = 17)		Non-Bev group (n = 31)
Regimens	N	Incidence of AE	N	Incidence of AE
CDDP + PEM	4	0	7	1
CBDCA + PEM	10	0	15	4
PEM	1	0	3	1
CBDCA + PTX	2	0	6	1
Total treatments	17	0	31	7
PEM-containing regimens	15	0	25	6

Data are expressed as number of patients. AE-ILD acute exacerbation of interstitial lung disease, CDDP cisplatin, PEM pemetrexed, CBDCA carboplatin, PTX paclitaxel